Cargando…
Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study
BACKGROUND: ESMO consensus recommends EGFR mutation testing in never/former light smokers (<15 pack-years) or patients with non-squamous NSCLC. The aim of this work was to determine the frequency and clinical predictors of EGFR mutations, and the role of specimen sampling tests, in Caucasian stan...
Autores principales: | Hantson, Inge, Dooms, Christophe, Verbeken, Eric, Vandenberghe, Peter, Vliegen, Liesbet, Roskams, Tania, Borght, Sara Vander, Nackaerts, Kris, Wauters, Isabelle, Vansteenkiste, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173071/ https://www.ncbi.nlm.nih.gov/pubmed/25264519 http://dx.doi.org/10.1186/s40247-014-0009-0 |
Ejemplares similares
-
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations
por: Vliegen, Liesbet, et al.
Publicado: (2015) -
ESMO20 YO for YO: highlights on oncogene-addicted NSCLC
por: Lim, K.H.J., et al.
Publicado: (2020) -
LBA78 A microsimulation model to assess the impact of SARS-CoV-2 on cancer outcomes, healthcare organization and economic burden
por: Van Mol, P., et al.
Publicado: (2020) -
LBA81 Keeping exhausted T-cells in check in COVID-19
por: Van Mol, P., et al.
Publicado: (2020) -
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
por: Douillard, Jean-Yves, et al.
Publicado: (2014)